IRIS
SARDU, Celestino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.044
AS - Asia 4.992
NA - Nord America 4.424
SA - Sud America 727
Continente sconosciuto - Info sul continente non disponibili 394
AF - Africa 82
OC - Oceania 8
Totale 20.671
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 6.616
US - Stati Uniti d'America 4.313
SG - Singapore 1.534
IT - Italia 1.345
CN - Cina 899
VN - Vietnam 881
IE - Irlanda 875
HK - Hong Kong 795
BR - Brasile 601
GB - Regno Unito 282
DE - Germania 280
IN - India 259
KR - Corea 250
FR - Francia 129
UA - Ucraina 119
JP - Giappone 98
TR - Turchia 70
FI - Finlandia 66
NL - Olanda 59
GR - Grecia 54
CA - Canada 47
SE - Svezia 45
AR - Argentina 38
BD - Bangladesh 38
MX - Messico 38
AT - Austria 35
EC - Ecuador 22
CZ - Repubblica Ceca 21
DK - Danimarca 21
PK - Pakistan 20
ZA - Sudafrica 20
ID - Indonesia 19
IQ - Iraq 19
PL - Polonia 19
BE - Belgio 17
CO - Colombia 17
IR - Iran 14
ET - Etiopia 13
PY - Paraguay 13
LT - Lituania 12
CL - Cile 11
IL - Israele 10
SA - Arabia Saudita 10
SC - Seychelles 10
EG - Egitto 9
MA - Marocco 9
PE - Perù 9
VE - Venezuela 9
AU - Australia 8
ES - Italia 8
UZ - Uzbekistan 8
KE - Kenya 7
PT - Portogallo 7
TW - Taiwan 7
AZ - Azerbaigian 6
CH - Svizzera 6
JO - Giordania 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
JM - Giamaica 5
MY - Malesia 5
TN - Tunisia 5
CR - Costa Rica 4
OM - Oman 4
RS - Serbia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
DZ - Algeria 3
EE - Estonia 3
GE - Georgia 3
HU - Ungheria 3
LV - Lettonia 3
NP - Nepal 3
SY - Repubblica araba siriana 3
AL - Albania 2
BB - Barbados 2
CY - Cipro 2
GT - Guatemala 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
MM - Myanmar 2
PA - Panama 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
AN - Antille olandesi 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
DM - Dominica 1
EU - Europa 1
GD - Grenada 1
HN - Honduras 1
Totale 20.267
Salva come PNG Salva come JPEG
Città #
Moscow 2.409
Dublin 866
San Jose 775
Hong Kong 761
Singapore 695
Santa Clara 518
Chandler 304
Ho Chi Minh City 288
Naples 278
Ashburn 269
Seoul 247
Jacksonville 217
Hanoi 216
Bengaluru 190
Hefei 190
Caserta 158
Dallas 154
The Dalles 144
Beijing 139
New York 104
Princeton 104
Roxbury 95
Los Angeles 90
Munich 83
Council Bluffs 77
Ann Arbor 75
Medford 70
São Paulo 62
Bremen 58
Da Nang 57
Aversa 50
Wilmington 48
Milan 43
Haiphong 38
Cambridge 36
Amsterdam 35
Woodbridge 34
Istanbul 31
Ercolano 30
Falkenstein 30
Salerno 28
Napoli 27
Orem 26
Des Moines 25
Rome 24
Chicago 22
Memphis 22
Nuremberg 22
Biên Hòa 21
Brno 19
Juelsminde 19
Boardman 18
Nanjing 18
Phoenix 18
Turku 18
Atlanta 17
Frankfurt am Main 17
Houston 17
Boydton 16
Brooklyn 16
Brussels 16
Vienna 16
Warsaw 16
Giugliano In Campania 15
Helsinki 15
Hải Dương 15
Mexico City 15
Sarno 14
Tokyo 14
Toronto 14
Addis Ababa 13
Chennai 13
Denver 13
Montreal 13
Mountain View 13
Rio de Janeiro 13
Shanghai 13
Bari 12
Brasília 12
London 12
Redwood City 12
San Mateo 12
Düsseldorf 11
Hillsboro 11
Lappeenranta 11
Ninh Bình 11
San Francisco 11
Tianjin 11
Johannesburg 10
Manchester 10
Paris 10
Porto Alegre 10
Belo Horizonte 9
Castellammare di Stabia 9
Guayaquil 9
Hyderabad 9
Nha Trang 9
Seattle 9
Vitulazio 9
Vũng Tàu 9
Totale 10.957
Salva come PNG Salva come JPEG
Nome #
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events 342
Abdominal fat SIRT6 expression and its relationship with inflammatory and metabolic pathways in pre-diabetic overweight patients 252
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 223
Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes. 205
123I-MIBG Scintigraphy in the Subacute State of Takotsubo Cardiomyopathy. 197
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 197
Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders 195
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study 188
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 188
Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment 186
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 185
Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: Effects of metformin 182
Awaking blood pressure surge and progression to microalbuminuria in type 2 normotensive diabetic patients 178
Cardiac syncope recurrence in type 2 diabetes mellitus patients vs. normoglycemics patients: The CARVAS study 175
Inflammatory cytokines and SIRT1 levels in subcutaneous abdominal fat: Relationship with cardiac performance in overweight pre-diabetics patients 172
MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients 169
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 166
Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts 165
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical beside 161
Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST-elevation myocardial infarction: effects on myocardial salvage 161
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 160
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 157
Molecular mechanisms and therapeutic targets of inflammatory-related Cardiovascular diseases: from molecular mechanisms to therapeutic targets 157
Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism? 157
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts 156
MRI in Pregnancy and Precision Medicine: A Review from Literature 156
Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients 155
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 155
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 154
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 152
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 152
Atherosclerotic plaque fissuration and clinical outcomes in pre-diabetics vs. normoglycemics patients affected by asymptomatic significant carotid artery stenosis at 2 years of follow-up: Role of micrornas modulation: The atimir study 152
Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis 151
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte 151
Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes 151
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 151
SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells 149
Acute Coronary Occlusion in Patients With Non-ST-Segment Elevation Out-of-Hospital Cardiac Arrest 149
Metformin therapy effects on the expression of sodium-glucose cotransporter 2, leptin, and sirt6 levels in pericoronary fat excised from pre-diabetic patients with acute myocardial infarction 148
[HIV and related infections in Italian penal institutions: epidemiological and health organization note] 147
Pre-Menopausal Breast Fat Density Might Predict MACE During 10 Years of Follow-Up: The BRECARD Study 147
Hyperglycaemia on admission to hospital and COVID-19 142
SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells 142
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients? 141
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 140
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 140
Metabolic syndrome is associated with a poor outcome in patients affected by outflow tract premature ventricular contractions treated by catheter ablation. 140
DNA methylation profiling of CD04+/CD08+ T cells reveals pathogenic mechanisms in increasing hyperglycemia: PIRAMIDE pilot study 140
Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism. 137
Use of a non-specific immunomodulation therapy as a therapeutic vasculogenesis strategy in no-option critical limb ischemia patients 137
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment 137
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry 136
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 135
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes 135
Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: Effects of incretin treatment 134
Cardiovascular benefits from gliflozins: Effects on endothelial function 134
Automated 3D Ultrasound as an Adjunct to Screening Mammography Programs in Dense Breast: Literature Review and Metanalysis 133
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study 132
Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19 132
Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome 132
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 131
Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up 131
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 131
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 131
Dietary Epigenetic Modulators: Unravelling the Still-Controversial Benefits of miRNAs in Nutrition and Disease 127
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 125
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque 125
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 125
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 125
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes 125
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 124
Effects of Alpha Lipoic Acid on Multiple Cytokines and Biomarkers and Recurrence of Atrial Fibrillation Within 1 Year of Catheter Ablation. 123
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 122
Advances in Nanomedicine for Precision Insulin Delivery 122
Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes. 122
Author's reply 121
Cardiac biomarkers predict 1-year mortality in elderly patients undergoing hip fracture surgery 121
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 120
Effects of α-lipoic acid therapy on sympathetic heart innervation in patients with previous experience of transient takotsubo cardiomyopathy 120
Functional role of miRNA in cardiac resynchronization therapy. 119
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry 118
Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes 118
Glycation of ryanodine receptor in circulating lymphocytes predicts the response to cardiac resynchronization therapy 118
Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes 117
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: Clinical outcomes at 1-year follow-up 117
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 117
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 117
The dating of thrombus organization in cases of pulmonary embolism: An autopsy study 116
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 115
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up (vol 17, pg 512, 2018) 114
Comparative Outcomes After Percutaneous Coronary Intervention in Unconscious and Conscious Patients With Out-of-Hospital Cardiac Arrest. 113
Effects of SGLT2i therapy on cardiac electrophysiological properties and arrhythmias in diabetic patients with implantable cardiac defibrillator 113
SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction 113
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 112
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 112
Calcium release channel RyR2 regulates insulin release and glucose homeostasis 111
Implications of AB0 blood group in hypertensive patients with covid-19 111
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry 110
NT-proBNP, IGF-I and survival in patients with chronic heart failure 109
Effects of metformin therapy on COronary endothelial DYsfunction in prediabetic patients With stable angina and Non Obstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study. 108
Totale 14.462
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.571
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022816 0 7 44 26 208 14 41 34 44 71 82 245
2022/20231.489 125 53 41 64 182 84 23 70 768 24 25 30
2023/2024921 58 58 40 50 243 106 20 18 17 49 89 173
2024/20253.003 40 50 30 103 381 349 445 294 368 460 242 241
2025/202612.615 569 784 677 556 929 6.201 1.011 647 457 392 228 164
2026/2027351 140 211 0 0 0 0 0 0 0 0 0 0
Totale 20.671